Skip to main content
Explore our network
All sites
DutyStation
Search
📰 GeneralCNBCThursday, October 29, 2026 at 10:13 AM UTC1h ago

Eli Lilly blows past estimates, hikes sales outlook as Zepbound and Mounjaro demand surge again

Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter

Read full article at CNBC →

Originally published by CNBC. Summary and curation by DutyStation News.

📰 Related Stories

📰 General

U.S. worker job engagement hits lowest level since 2011, new Gallup poll finds

CNBC17m ago
📰 General

Alphabet earnings miss reflects first real sign that AI is taking a bite out of search

CNBC34m ago
Google had a very good, very bad Q3
📰 General

Google had a very good, very bad Q3

9to5Google34m ago
Motorola has already confirmed its Signature 27 flagship is launching in November
📰 General

Motorola has already confirmed its Signature 27 flagship is launching in November

9to5Google34m ago
📰 General

Restaurant Brands reports mixed results as Burger King's U.S. turnaround shows signs of success

CNBC1h ago
📰 General

Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength

CNBC1h ago
← Back to News